(Press-News.org) In a large, nationwide study led by the American Cancer Society (ACS), researchers found mortality risks for smoking menthol cigarettes were higher than non-menthol cigarettes for death from any cause and cardiovascular diseases, especially heart diseases. Higher risks were evident in individuals who had quit smoking and at high smoking intensities. Black participants currently smoking menthol brands had high increases for some heart diseases with an 88% elevated mortality risk compared to non-menthol cigarettes. The report also showed quitting smoking substantially reduced health risks from both cigarette types. The findings are published today in the journal Tobacco Control.
“Menthol in cigarettes is an established public health threat due to its effect on increasing smoking uptake and reducing smoking cessation,” said Dr. Priti Bandi, scientific director, risk factors and screening research at the American Cancer Society and lead author of the study. “With these results additionally showing unique mortality effects, it’s time for menthol cigarettes to be regulated to help save lives. In the U.S. and globally in many low- and middle-income countries, the share of menthol cigarettes in the market is substantial.”
For the report, researchers followed nearly a million people from the Cancer Prevention Study II, a population-based prospective cohort enrolled in 1982-1983, and observed them for mortality outcomes over six years. All-cause and cause-specific mortality risk was assessed according to baseline smoking status (current, former, never) and menthol flavor status (menthol, non-menthol) of the cigarette brand smoked for the longest period.
Among 73,486 participants reporting menthol brands and 281,680 participants reporting non-menthol brands, there were 4,071 and 20,738 deaths, respectively. Participants currently smoking menthol or non-menthol cigarette brands had similarly high mortality risks compared to never smoking (e.g., death from any cause was about 2 times higher), but quitting substantially reduced the risk of death from both types of cigarettes. Among people who had quit smoking, a history of menthol versus non-menthol smoking was associated with an increased mortality risk of 12% from all causes, 16% from all cardiovascular diseases, 13% from ischemic or coronary artery disease, and 43% from other heart diseases. Among individuals currently smoking, there was no difference in mortality risks for menthol vs. non-menthol cigarettes, except for an elevated risk among those smoking 40 or more cigarettes per day and in Black individuals for some heart diseases.
“Continuing to smoke, whether menthol or non-menthol cigarettes, is the most harmful,” added Bandi. “These findings reiterate that quitting all cigarette types is the only safe option to reduce your risk of disease and dying prematurely.”
“Today’s study proves once again why policymakers need to enact comprehensive policies that help individuals who currently use quit and prevent youth and young adults from becoming addicted to tobacco products,” said Lisa A. Lacasse, president of ACS’s advocacy affiliate, the American Cancer Society Cancer Action Network (ACS CAN). “People who smoke deserve barrier-free access to comprehensive cessation services and support through quitlines, their health care providers, and state and federal programs. ACS CAN will continue to work to increase funding for tobacco prevention and cessation programs, end the sale of menthol cigarettes and all other flavored tobacco products, and enact other proven tobacco control policies, including comprehensive smoke-free laws and regular and significant tax increases on all tobacco products.”
Other ACS researchers contributing to the study include Christina Newton, Zheng Xue, Dr. Samuel Asare, Dr. Minal Patel, Dr. Farhad Islami, Dr. Nigar Nargis, Dr. Alpa Patel, Dr. Ahmedin Jemal, Dr. J. Lee Westmaas, and senior author Ryan Diver.
Additional ACS Resources:
Menthol Flavored Cigarette Information
Tobacco Control Research
Tobacco Cessation
Cancer Statistics Center
# # #
About the American Cancer Society
The American Cancer Society is a leading cancer-fighting organization with a vision to end cancer as we know it, for everyone. For more than 110 years, we have been improving the lives of people with cancer and their families as the only organization combating cancer through advocacy, research, and patient support. We are committed to ensuring everyone has an opportunity to prevent, detect, treat, and survive cancer. To learn more, visit cancer.org or call our 24/7 helpline at 1-800-227-2345. Connect with us on Facebook, X, and Instagram.
END
New ACS study finds menthol flavored cigarette smoking increases mortality risk vs. non-menthol cigarettes
2025-02-13
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Discussing barriers, concerns key for getting older adults vaccinated
2025-02-13
A clear endorsement from their healthcare provider and being supplied information about recommended vaccines before their clinic visit spurred more older Americans to get vaccinated, a new University of Virginia School of Medicine study found.
Because immune systems age like the rest of the body, older adults are at higher risk for poor outcomes from infections. But only 15% of Americans ages 50 and older and 25% of Americans ages 65 and older are up to date on all recommended vaccines, including flu, RSV, tetanus and pneumococcal disease.
In the study, six primary care clinics across America piloted a new approach to boosting vaccination rates. This included ...
Regular access to therapy dogs boosts first-year students’ mental health
2025-02-13
PULLMAN, Wash. — College students who spent a little bit of free time each week interacting with therapy dogs on campus during their first semester experienced fewer signs of stress and depression than those who did not.
That’s according to the PAWs4US study, a new paper published in Pets that examined how regular, long-term access to an animal-assisted drop-in program at Washington State University influenced first-year students’ mental health.
The study found that students who engaged with therapy dogs in repeated, unstructured sessions over several months not only ...
The complicated question of how we determine who has an accent
2025-02-13
COLUMBUS, Ohio – How do you tell if someone has a particular accent? It might seem obvious: You hear someone pronounce words in a way that is different from “normal” and connect it to other people from a specific place.
But a new study suggests that might not be the case.
“People probably don’t learn who has an accent from hearing someone talk and thinking, ‘huh, they sound funny’ – even though sometimes it feels like that’s how we do it,” said Kathryn Campbell-Kibler, author of the study and associate professor of linguistics at The Ohio State University.
Accents may be ...
NITech researchers shed light on the mechanisms of bacterial flagellar motors
2025-02-13
When speaking of motors, most people think of those powering vehicles and human machinery. However, biological motors have existed for millions of years in microorganisms. Among these, many bacterial species have tail-like structures—called flagella—that spin around to propel themselves in fluids. These movements employ protein complexes known as the “flagellar motor.”
This flagellar motor consists of two main components: the rotor and the stators. The rotor is a large rotating structure, anchored to the cell membrane, that turns the flagellum. On the other hand, the stators are smaller ...
Study maps new brain regions behind intended speech
2025-02-13
Broca’s aphasia is caused by damage to the frontal lobe, leaves patients unable to say what they intend to say
First study to identify regions outside the frontal lobe that encode the intent to speak
Critical for technology to avoid decoding a patient’s thoughts that are not intended to be spoken aloud
CHICAGO --- Imagine seeing a furry, four-legged animal that meows. Mentally, you know what it is, but the word “cat” is stuck on the tip of your tongue.
This phenomenon, known as Broca’s aphasia or expressive aphasia, is a language disorder that affects a person’s ability to speak or ...
Next-gen Alzheimer’s drugs extend independent living by months
2025-02-13
In the past two years, the Food and Drug Administration has approved two novel Alzheimer’s therapies, based on data from clinical trials showing that both drugs slowed the progression of the disease. But while the approvals of lecanemab and donanemab, both antibody therapies that clear plaque-causing amyloid proteins from the brain, were greeted with enthusiasm by some Alzheimer’s researchers, the response of patients has been muted. According to physicians who care for people with Alzheimer’s, many patients found it difficult to understand what the clinical trials results — presented as “percent decrease in ...
Jumping workouts could help astronauts on the moon and Mars, study in mice suggests
2025-02-13
Jumping workouts could help astronauts prevent the type of cartilage damage they are likely to endure during lengthy missions to Mars and the Moon, a new Johns Hopkins University study suggests.
The research adds to ongoing efforts by space agencies to protect astronauts against deconditioning/getting out of shape due to low gravity, a crucial aspect of their ability to perform spacewalks, handle equipment and repairs, and carry out other physically demanding tasks.
The study, which shows knee cartilage in mice grew healthier following jumping exercises, appears ...
Guardian molecule keeps cells on track – new perspectives for the treatment of liver cancer
2025-02-13
A guardian molecule ensures that liver cells do not lose their identity. This has been discovered by researchers from the German Cancer Research Center (DKFZ), the Hector Institute für Translational Brain Research (HITBR), and from the European Molecular Biology Laboratory (EMBL). The discovery is of great interest for cancer medicine because a change of identity of cells has come into focus as a fundamental principle of carcinogenesis for several years. The Heidelberg researchers were able to show ...
Solar-powered device captures carbon dioxide from air to make sustainable fuel
2025-02-13
Researchers have developed a reactor that pulls carbon dioxide directly from the air and converts it into sustainable fuel, using sunlight as the power source.
The researchers, from the University of Cambridge, say their solar-powered reactor could be used to make fuel to power cars and planes, or the many chemicals and pharmaceuticals products we rely on. It could also be used to generate fuel in remote or off-grid locations.
Unlike most carbon capture technologies, the reactor developed by the Cambridge researchers does not require fossil-fuel-based power, or the transport and storage of carbon dioxide, but instead converts atmospheric CO2 into something useful using sunlight. ...
Bacteria evolved to help neighboring cells after death, new research reveals
2025-02-13
Darwin’s theory of natural selection provides an explanation for why organisms develop traits that help them survive and reproduce.
Because of this, death is often seen as a failure rather than a process shaped by evolution.
When organisms die, their molecules need to be broken down for reuse by other living things.
Such recycling of nutrients is necessary for new life to grow.
Now a study led by Professor Martin Cann of ...